Nutex Health Inc.
NUTX
$123.54
-$16.97-12.08%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 226.95% | 3.57% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 226.95% | 3.57% | |||
| Cost of Revenue | 113.29% | 5.96% | |||
| Gross Profit | 446.34% | -0.76% | |||
| SG&A Expenses | 131.88% | 11.69% | |||
| Depreciation & Amortization | 6.19% | 9.70% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 108.74% | 7.17% | |||
| Operating Income | 1,032.02% | -15.72% | |||
| Income Before Tax | 4,307.63% | -166.10% | |||
| Income Tax Expenses | 87.78% | 412.86% | |||
| Earnings from Continuing Operations | 1,495.24% | -338.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -2,257.77% | 51.89% | |||
| Net Income | 802.02% | -2,314.37% | |||
| EBIT | 1,032.02% | -15.72% | |||
| EBITDA | 945.98% | -13.53% | |||
| EPS Basic | 786.51% | -2,250.89% | |||
| Normalized Basic EPS | 1,073.90% | -189.46% | |||
| EPS Diluted | 745.10% | -2,250.89% | |||
| Normalized Diluted EPS | 1,015.45% | -189.46% | |||
| Average Basic Shares Outstanding | 2.26% | 2.62% | |||
| Average Diluted Shares Outstanding | 8.79% | 2.62% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||